Arcturus Therapeutics Received Approval from Singapore Health Sciences Authority to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate and Provides New and Updated Clinical and Preclinical Data

… has received approval from the Singapore Health Sciences Authority to proceed … ’ commitment to the development of novel RNA therapeutics has led to … [email protected] KEYWORD: CALIFORNIA SINGAPORE UNITED STATES NORTH AMERICA ASIA …